Identification of Independent and Communal Differentially Expressed Genes as Well as Potential Therapeutic Targets in Ischemic Heart Failure and Non-Ischemic Heart Failure

被引:1
|
作者
Wang, Zuoxiang [1 ,2 ]
Zhang, Mingyang [1 ,2 ]
Xu, Yinan [1 ,2 ]
Gu, Yiyu [1 ,2 ]
Song, Yumeng [1 ,2 ]
Jiang, Tingbo [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Dept Cardiol, 188 Shizi Rd, Suzhou 215006, Jiangsu, Peoples R China
[2] Soochow Univ, Dept Med, Suzhou, Jiangsu, Peoples R China
来源
PHARMACOGENOMICS & PERSONALIZED MEDICINE | 2021年 / 14卷
关键词
bioinformatical analysis; differentially expressed genes; hub genes; heart failure; ischemic heart failure; non-ischemic heart failure; INTEGRATION; NETWORKS; ETIOLOGY; SERVER;
D O I
10.2147/PGPM.S313621
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Heart failure (HF) is a rapidly growing public health problem, and its two main etiological types are non-ischemic heart failure (NIHF) and ischemic heart failure (IHF). However, the independent and common mechanisms of NIHF and IHF have not been fully elucidated. Here, bioinformatic analysis was used to characterize the difference and independent pathways for IHF and NIHF, and more importantly, to unearth the common potential markers and therapeutic targets in IHF and NIHF. Methods: Two data sets with accession numbers GSE26887 and GSE84796 were downloaded from the Gene Expression Omnibus (GEO) database. After identifying the independent and communal DEGs of NIHF and IHF, a functional annotation, protein-protein interaction (PPI) network analysis, co-expression and drug-gene interaction prediction analysis, and mRNA-miRNA regulatory network analysis were performed for DEGs. Results: We found 1146 independent DEGs (DEGs2) of NIHF mainly enriched in transcription-related and 2595 independent DEGs (DEGs3) of IHF mainly enriched in immune-related. Moreover, 185 communal DEGs (DEGs1) were found between NIHF and IHF, including 93 upregulated genes and 92 downregulated genes. Pathway enrichment analysis results showed that GPCR pathways and biological processes are closely related to the occurrence of HF. In addition, three hub genes were identified from PPI network, including CCL5, C5 and TLR3. Conclusion: The identification of DEGs and hub genes in this study contributes to a novel perception for potential functional mechanisms and biomarkers or therapeutic targets in NIHF and IHF.
引用
收藏
页码:683 / 693
页数:11
相关论文
共 50 条
  • [1] The Lymphocyte Count and Neutrophil/lymphocyte Ratio are Independent Predictors for Adverse Cardiac Events in Ischemic Heart Failure but not with Non-ischemic Heart Failure
    Farcas, Anca Daniela
    Stoia, Mirela Anca
    Anton, Florin Petru
    Hognogi, Diana Mocan
    Ianos, Raluca Diana
    Hojda, Silvana Elena Susca
    Gavrila, Iulia Laura
    Lutac, Delia
    Burian, Irina Ioana
    Simiti, Luminita Animarie Vida
    REVISTA DE CHIMIE, 2016, 67 (10): : 2091 - 2094
  • [2] Mitochondrial function in heart failure: The impact of ischemic and non-ischemic etiology
    Park, Song-Young
    Trinity, Joel D.
    Gifford, Jayson R.
    Diakos, Nikolaos A.
    McCreath, Lauren
    Drakos, Stavros
    Richardson, Russell S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 220 : 711 - 717
  • [3] Comparison of Inflammatory Markers in Patients with Ischemic and Non-ischemic Heart Failure
    Karabacak, Mustafa
    Dogan, Abdullah
    Varol, Ercan
    Uysal, Bayram Ali
    Yildiz, Ibrahim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : C137 - C138
  • [4] Contemporary Challenges of Regenerative Therapy in Patients with Ischemic and Non-Ischemic Heart Failure
    Banovic, Marko
    Poglajen, Gregor
    Vrtovec, Bojan
    Ristic, Arsen
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (12)
  • [5] Ischemic and non-ischemic patterns of late gadolinium enhancement in heart failure with reduced ejection fraction
    Matusik, Patrycja S.
    Bryll, Amira
    Matusik, Pawel T.
    Popiela, Tadeusz J.
    CARDIOLOGY JOURNAL, 2021, 28 (01) : 67 - 76
  • [6] Long-term impact of diabetes in patients hospitalized with ischemic and non-ischemic heart failure
    Andersson, Charlotte
    Weeke, Peter
    Pecini, Redi
    Kjaergaard, Jesper
    Hassager, Christian
    Kober, Lars
    Torp-Pedersen, Christian
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2010, 44 (01) : 37 - 44
  • [7] Beneficial effects of statins in patients with non-ischemic heart failure
    Laufs, U
    Wassmann, S
    Schackmann, S
    Heeschen, C
    Böhm, M
    Nickenig, G
    ZEITSCHRIFT FUR KARDIOLOGIE, 2004, 93 (02): : 103 - 108
  • [8] Prevalence of sleep-related breathing disorders in ischemic and non-ischemic heart failure
    Oldenburg, O.
    Lamp, B.
    Toepfer, V.
    Faber, L.
    Teschler, H.
    Horstkotte, D.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2007, 132 (13) : 661 - 666
  • [9] Anemia and renal failure as predictors of risk in a mainly non-ischemic heart failure population
    Ferreira, Silvia M. A.
    Guimaraes, Guilherme V.
    Cruz, Ftima D.
    Issa, Vitor S.
    Bacal, Fernando
    Souza, Germano E. C.
    Chizzola, Paulo R.
    Mangini, Sandrigo
    Bocchi, Edimar A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 141 (02) : 198 - 200
  • [10] Impaired coronary flow reserve in patients with non-ischemic heart failure
    Coma-Canella, I
    García-Velloso, MJ
    Macías, A
    Villar, L
    Cosín-Sales, J
    Martí-Climent, JM
    Artaiz, M
    REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56 (04): : 354 - 360